Chemical activators of Svs2 can engage various cellular pathways to facilitate its activation. Phorbol 12-myristate 13-acetate (PMA) is one such activator, which directly stimulates Protein Kinase C (PKC). The activation of PKC is a critical step that can lead to the phosphorylation of numerous proteins, one of which can be Svs2. This phosphorylation event can result in a conformational change in Svs2, promoting its activation. Similarly, Forskolin, by elevating intracellular cAMP levels, activates protein kinase A (PKA), which can subsequently phosphorylate Svs2, leading to its activation. Another route of activation is through the manipulation of intracellular calcium levels, as induced by Ionomycin. The increase in calcium can activate calcium-dependent kinases that may target Svs2 for phosphorylation and activation.
Further, Svs2 activation can be sustained through the inhibition of phosphatases by compounds such as Calyculin A and Okadaic Acid, which prevent the dephosphorylation of proteins, thereby keeping Svs2 in an active state. Epidermal Growth Factor (EGF) stimulates its receptor, setting off a signaling cascade that can culminate in the phosphorylation and activation of Svs2. Anisomycin, through its activation of stress-activated protein kinases, provides another means to phosphorylate and activate Svs2. Thapsigargin disrupts calcium homeostasis, indirectly triggering pathways that can lead to the phosphorylation and activation of Svs2. Bisindolylmaleimide I, although primarily a PKC inhibitor, can elicit a counteractive cellular response that activates Svs2. Dibutyryl cAMP functions similarly to Forskolin, in that it activates PKA, which can then target Svs2 for activation via phosphorylation. Sodium Orthovanadate's inhibition of tyrosine phosphatases can result in the maintenance of Svs2 in a phosphorylated, active state. Lastly, Piceatannol, by inhibiting Syk kinase, can alter signaling pathways in a manner that leads to the activation of Svs2. Each of these chemicals employs a distinct mechanism to influence the activation state of Svs2, underscoring the complexity and interconnectivity of cellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC) which is known to phosphorylate a myriad of proteins, potentially including activation of Svs2. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent kinases that may phosphorylate and activate Svs2. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, maintaining proteins like Svs2 in a phosphorylated and active state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases, which can lead to the phosphorylation and subsequent activation of Svs2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis and could lead to activation of Svs2 through calcium-dependent phosphorylation pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound inhibits PKC, potentially causing compensatory cellular responses that activate Svs2. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP, a cAMP analog, activates PKA which could phosphorylate and thus activate Svs2. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium Orthovanadate inhibits protein tyrosine phosphatases, potentially maintaining Svs2 in an active state. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Piceatannol inhibits Syk kinase, potentially altering signaling pathways that lead to the activation of Svs2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, which can lead to the phosphorylation and activation of Svs2. | ||||||